GT Apeiron Therapeutics logo
Healthcare & Life Sciences

GT Apeiron Therapeutics

GT Apeiron Therapeutics is a Healthcare & Life Sciences startup based in China.

About GT Apeiron Therapeutics

GT Apeiron Therapeutics is a company headquartered in China. Brouky classifies it under Healthcare & Life Sciences.

GT Apeiron Therapeutics is a clinical-stage small molecule biotech company based in Shanghai and San Francisco, developing biomarker-driven cancer therapeutics including a PRMT5 inhibitor in Phase 1 clinical trials and a KIF18A inhibitor with a differentiated profile.

Explore GT Apeiron Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in China